FG

Farhanmujib Gena

Active Director Director DIN 10911612
DIN 10911612 First appointment Jan 2025 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Farhanmujib Gena

Data last updated:

Farhanmujib Gena is a Director at Ksf Remedies Private Limited (since 2025). The company operates in Paper.

DIN 10911612
Primary Designation Director
Industry Paper
First Appointment 20 Jan 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ksf Remedies Private Limited U21001GJ2024PTC157295
Director20 Jan 20252024Active

Directorship timeline

Open interactive timeline →
Ksf Remedies Private Limited
Premium access

Shareholding and investment profile for Farhanmujib Gena

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Farhanmujib Gena

Farhanmujib Gena currently holds 1 directorship: Ksf Remedies Private Limited (Director, since 20 Jan 2025).

Farhanmujib Gena was first appointed on 20 Jan 2025 as Director at Ksf Remedies Private Limited.

The current boards of Farhanmujib Gena's companies include Aayeshakhatun Naimuddin Kazi (Ksf Remedies Private Limited), Karishma Jamilahmed Khanji (Ksf Remedies Private Limited), Mohamadfaruk Ganibhai Champaneriya (Ksf Remedies Private Limited), Sajjadhusen Mohammedsalim Suthar (Ksf Remedies Private Limited), Sherbanu Rizvan Sabaliya (Ksf Remedies Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available